Staten Island Urological Rsrch entered the industry of Tattooing in 2009 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 6211110, which describes it as a Tattooing. For further clarification, the SIC classifies this business under the code 7299 and described it as a Tattooing. The business provides service to the B2C market.
To acquire more information, please contact Debbie Munno, Office Manager by calling (718) 720-6040 during business hours. You can also write to the business’ Single Location at 1800 Clove Road # 2, Staten Island, New York NY 10304. You can also visit the company’s website at urocancer.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Staten Island Urological Rsrch |
| Representative: | Debbie Munno, Office Manager |
| Place of Business: | 1800 Clove Road # 2, Staten Island, NY 10304 |
| Contact Number: | (718) 720-6040 |
| Website: | urocancer.com |
| Type of Service: | Tattooing |
| SIC Number: | 7299 |
| NAICS Number: | 6211110 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 2009 |
| Income/Year: | $1.000.000 to $2.499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Staten Island Urological Rsrch is a company operating from Richmond, New York providing professional Tattooing and relevant B2C variables. It was founded in 2009 and registered with the SIC code 7299 as Tattooing, and with the NAICS code 6211110 as Tattooing.
With a current employee count of 1 to 4, Staten Island Urological Rsrch has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Debbie Munno, Office Manager at (718) 720-6040 for related queries, or to locate its Single Location using the coordinates 40.60821,-74.09041.
The Single Location can also be found at the street address 1800 Clove Road # 2 in Staten Island, New York 10304 and can be engaged online through the company website at urocancer.com, the company Twitter , and Facebook page .